JNJ

Johnson & Johnson executives are scheduled to take the stand in a trial starting Monday. ChemImage, a small biotech firm,...

While J&J is yet to give up on aticaprant, it decides to stop developing the drug for major depressive disorder...

Generating passive income is a core aspect of my financial strategy. My goal is to eventually produce enough recurring investment...

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on...

Those who own JNJ stock may stay invested for some time as the company looks optimistic about a better performance...

Those who own JNJ stock may stay invested for some time as the company looks optimistic about a better performance...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23%...

JNJ's filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of antibody-positive patients.

You will want to build your portfolio the right way if you're going to make money with stocks over the...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.